基本資料/Profiles

廖顯鋒／Hsien-Feng Liao

任職單位/ Academic Appointments  

中國醫藥大學附設醫院 身心介面研究中心 博士後研究員

Mind-Body Interface Research Center (MBI),

China Medical University Hospital Postdoctoral Fellow

學歷/Education

中國醫藥大學 癌症生物與藥物研發學位學程 藥學博士

Doctor of Philosophy in Pharmacy, the Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taiwan (2011-2016)

中國醫藥大學 藥學系暨碩博士班 碩士

MS in Science of Pharmacy, School of Pharmacy, China Medical University, Taiwan (2009-2011)

中國醫藥大學 藥學系 學士

BS in Science of Pharmacy, School of Pharmacy, China Medical University, Taiwan (1998-2002)

經歷/ Professional Experiences

1. 百歐精準生物醫學股份有限公司 醫藥基因組研究員(20171101-20220930)

            AllBio Life Co., Ltd, Researcher

2. 財團法人生物技術開發中心 研究員(20190101-20191231)

          Development Center for Biotechnology, Researcher (RAISE, MOST)

3. 仁德醫護管理專科學校 兼任助理教授(20220101)

          Jenteh Junior College of Medicine, Nursing and Management, Adjunct Assistant Professor

4. 苑裡李綜合醫院 藥劑科 藥師 (20170105-20190424)

          Department of Pharmacy, Yuanli Lee's General Hospital, Pharmacist

5. 林新醫療社團法人林新醫院 藥劑部 藥師 (20070801-20110417)

           Department of Pharmacy, Lin Shin Hospital, Pharmacist

期刊論文／Journal Paper

1. Ying-Ping Juan, Hsien-Feng Liao, Hung Yao Chen*; A Discussion on the Pharmaco-microbiomics; Formosa Journal of Clinical Pharmacy Vol. 29 No. 4(2021), p. 198-205. DOI：10. 6168/FJCP.202110_29(4).0002.
2. Hsien-Feng Liao, Ying-Ping Juan, Chun-Hsu Pan*; Discussion on Pharmacogenetic Researches of Fatty Acid Amide Hydrolase. THE JOURNAL OF TAIWAN PHARMACY Vol.35 No.3 Sep. 30 2019, ISSN 2220-6493.
3. Hsien-Feng Liao*, Ying-Ping Juan, Pei-Chiang Chen, Ming-Jyh Sheu; The Correlation Between Clopidogrel and the CES1 (rs71647871) Polymorphism. Formosa Journal of Clinical Pharmacy  Vol. 27 No. 4(2019), p. 274-280. DOI:10.6168/FJCP. 201910_27(4).0003.
4. Hsien-Feng Liao+, Chun-Hsu Pan+, Pei-Yu Chou, Yi-Fong Chen, Tian-Shung Wu*, Ming-Jyh Sheu*, Chieh-Hsi Wu*; Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells. PLoS One 12(9): e0185021. doi:10.1371/journal. pone.0185021.eCollection 2017.
5. Liao HF, Lee HH, Chang YS, Lin CL, Liu TY, Chen YC, Yen JC, Lee YT, Lin CY, Wu SH, Ko YC*, Chang JG*; Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers. Scientific Reports 6:27350. doi: 10.1038/srep27350.
6. Liao HF, Lee CC, Hsiao PC, Chen YF, Tseng CH, Tzeng CC, Chen YL, Chen JC, Chang YS*, Chang JG*; TCH1036, a indeno [1,2-c] quinoline derivative, potentially inhibited the growth of human brain malignant glioma (GBM) 8401 cells via suppression of the expression of Suv39h1 and PARP. Biomedicine & Pharmacotherapy 82:649-59. doi: 10.1016/j.biopha.2016.06.002. Epub 2016 Jun 13.

研討會論文／Conference Papers

1. 定序解讀UGT1A1*28 (rs3064744)藥物基因體學；第二屆台灣藥學聯合學術研討會 2020.11.08.

Contact

電話：0958-638865

E-mail：neoandersonliao@gmail.com

ORCID：https://orcid.org/0000-0002-8747-5097